Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 128 articles: HTML format Text format

Single Articles

February 2012
1. 
   Targeted therapy in non-small lung cancer.
   Anticancer Res. 2012;32:719.
   PubMed     Text format     Related articles   
   
   
   
   
2. SHUKUYA T , Takahashi T, Harada H, Akamatsu H, et al
   Comparison of Vinorelbine plus Cisplatin and S-1 plus Cisplatin in Concurrent Chemoradiotherapeutic Regimens for Unresectable Stage III Non-small Cell Lung Cancer.
   Anticancer Res. 2012;32:675-80.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. AOKI T , Igawa S, Furuya N, Katagiri M, et al
   Impacts of Treatment Lines and Initiation Timing of Erlotinib for Advanced Non-small Cell Lung Cancer.
   Anticancer Res. 2012;32:601-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RICHARDSON F , Young GD, Sennello R, Wolf J, et al
   The Evaluation of E-Cadherin and Vimentin as Biomarkers of Clinical Outcomes Among Patients with Non-small Cell Lung Cancer Treated with Erlotinib as Second- or Third-line Therapy.
   Anticancer Res. 2012;32:537-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SUCHAOIN W , Chanvorachote P
   Caveolin-1 Attenuates Hydrogen Peroxide-induced Oxidative Damage to Lung Carcinoma Cells.
   Anticancer Res. 2012;32:483-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
6. NORTON R , O'Connell MA
   Vitamin d: potential in the prevention and treatment of lung cancer.
   Anticancer Res. 2012;32:211-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. NIEDER C , Tollali T, Norum J, Pawinski A, et al
   A Population-based Study of the Pattern of Terminal Care and Hospital Death in Patients with Non-small Cell Lung Cancer.
   Anticancer Res. 2012;32:189-94.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KOSMIDIS PA , Syrigos K, Kalofonos HP, Dimopoulos MA, et al
   Vinorelbine versus Paclitaxel for Patients with Advanced Non-small Cell Lung Cancer (NSCLC) and a Performance Status of 2.
   Anticancer Res. 2012;32:175-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SHIN KC , Choi EY, Chung JH, Jeon C, et al
   Clinical Application of MAGE A1-6 RT-Nested PCR for Diagnosis of Lung Cancer Invisible by Bronchoscopy.
   Anticancer Res. 2012;32:163-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TIAN F , Schrodl K, Kiefl R, Huber RM, et al
    The Hedgehog Pathway Inhibitor GDC-0449 Alters Intracellular Ca2+ Homeostasis and Inhibits Cell Growth in Cisplatin-resistant Lung Cancer Cells.
    Anticancer Res. 2012;32:89-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
11. TAKENAKA M , Hanagiri T, Shinohara S, Kuwata T, et al
    The Prognostic Significance of HER2 Overexpression in Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:4631-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. KOBAYASHI M , Sonobe M, Takahashi T, Yoshizawa A, et al
    Clinical Significance of BRAF Gene Mutations in Patients with Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:4619-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. INOMATA M , Shukuya T, Takahashi T, Ono A, et al
    Continuous Administration of EGFR-TKIs Following Radiotherapy after Disease Progression in Bone Lesions for Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:4519-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HERPEL E , Jensen K, Muley T, Warth A, et al
    The Cancer Stem Cell Antigens CD133, BCRP1/ABCG2 and CD117/c-KIT Are Not Associated with Prognosis in Resected Early-stage Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:4491-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
15. PESTA M , Kulda V, Kucera R, Pesek M, et al
    Prognostic Significance of TIMP-1 in Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:4031-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LUMACHI F , Marino F, Fanti G, Chiara GB, et al
    Serum N-Telopeptide of Type I Collagen and Bone Alkaline Phosphatase and Their Relationship in Patients with Non-small Cell Lung Carcinoma and Bone Metastases. Preliminary Results.
    Anticancer Res. 2011;31:3879-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KAIRA K , Takahashi T, Murakami H, Shukuya T, et al
    Relationship between LAT1 Expression and Response to Platinum-based Chemotherapy in Non-small Cell Lung Cancer Patients with Postoperative Recurrence.
    Anticancer Res. 2011;31:3775-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SAINI SS , Klein MA
    Targeting Cyclin D1 in Non-small Cell Lung Cancer and Mesothelioma Cells by Antisense Oligonucleotides.
    Anticancer Res. 2011;31:3683-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
19. PAZDIORA P , Svobodova S, Fuchsova R, Kucera R, et al
    Vitamin d in colorectal, breast, prostate and lung cancer: a pilot study.
    Anticancer Res. 2011;31:3619-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. HSIA TC , Liu CJ, Lin CH, Chang WS, et al
    Interaction of CCND1 Genotype and Smoking Habit in Taiwan Lung Cancer Patients.
    Anticancer Res. 2011;31:3601-3605.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HSU NY , Wu JY, Liu X, Yen Y, et al
    Expression Status of Ribonucleotide Reductase Small Subunits hRRM2/p53R2 as Prognostic Biomarkers in Stage I and II Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:3475-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. CHOI DR , Lee DH, Choi CM, Kim SW, et al
    Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II Study.
    Anticancer Res. 2011;31:3457-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. HOSOMI Y , Shibuya M, Niho S, Ichinose Y, et al
    Phase II Study of Topotecan with Cisplatin in Japanese Patients with Small Cell Lung Cancer.
    Anticancer Res. 2011;31:3449-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. HUANG TH , Chiu SJ, Chiang PH, Chiou SH, et al
    Antiproliferative effects of N-heterocyclic indolyl glyoxylamide derivatives on human lung cancer cells.
    Anticancer Res. 2011;31:3407-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HUNTER TB , Manimala NJ, Luddy KA, Catlin T, et al
    Paclitaxel and TRAIL Synergize to Kill Paclitaxel-resistant Small Cell Lung Cancer Cells through a Caspase-independent Mechanism Mediated through AIF.
    Anticancer Res. 2011;31:3193-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CASTO BC , Pereira MA
    Prevention of mouse lung tumors by combinations of chemopreventive agents using concurrent and sequential administration.
    Anticancer Res. 2011;31:3279-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
27. PRAZAKOVA M , Vrzalova J, Auge JM, Safranek J, et al
    The Role of MonoTotal in the Primary Diagnosis, Prognosis and Follow-up of Patients with Non-small Cell Lung Cancer (NSCLC).
    Anticancer Res. 2011;31:3107-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. TOMITA M , Shimizu T, Ayabe T, Yonei A, et al
    Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:2995-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PIRCHER A , Ulsperger E, Hack R, Jamnig H, et al
    Basic Clinical Parameters Predict Gefitinib Efficacy in Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:2949-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. WERYNSKA B , Pula B, Muszczynska-Bernhard B, Piotrowska A, et al
    Correlation between Expression of Metallothionein and Expression of Ki-67 and MCM-2 Proliferation Markers in Non-Small Cell Lung Cancer.
    Anticancer Res. 2011;31:2833-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KAIRA K , Okumura T, Ohde Y, Takahashi T, et al
    Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer.
    Anticancer Res. 2011;31:2763-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. NISHIDA H , Shirai T, Hayashi K, Takeuchi A, et al
    Cryotreatment against metastatic renal cell bone tumour reduced multiple lung metastases.
    Anticancer Res. 2011;31:2927-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. KEOHAVONG P , Kahkonen B, Kinchington E, Yin J, et al
    K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation.
    Anticancer Res. 2011;31:2877-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
34. LUO W , Schork NJ, Marschke KB, Ng SC, et al
    Identification of Polymorphisms Associated with Hypertriglyceridemia and Prolonged Survival Induced by Bexarotene in Treating Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:2303-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. AKSOY-SAGIRLI P , Cakmakoglu B, Isbir T, Kaytan-Saglam E, et al
    Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population.
    Anticancer Res. 2011;31:2225-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. TAE N , Seo J, Min BS, Ryoo S, et al
    3-Oxoolean-12-en-27-oic Acid Inhibits the Proliferation of Non-small Cell Lung Carcinoma Cells by Inducing Cell-cycle Arrest at G0/G1 Phase.
    Anticancer Res. 2011;31:2179-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. WANG L , Raju U, Milas L, Molkentine D, et al
    Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells.
    Anticancer Res. 2011;31:2141-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. OKAICHI K , Nose K, Kotake T, Izumi N, et al
    Phosphorylation of p53 modifies sensitivity to ionizing radiation.
    Anticancer Res. 2011;31:2255-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LEE SJ , Lee HJ, Moon DH
    Quantitative analysis of thymidine kinase 1 and 5'(3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake.
    Anticancer Res. 2011;31:2135-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. SATO M , Tsujino I, Fukunaga M, Mizumura K, et al
    Cyclosporine A induces apoptosis of human lung adenocarcinoma cells via caspase-dependent pathway.
    Anticancer Res. 2011;31:2129-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. KUEMMERLE A , Yan H, Krueger T, Buclin T, et al
    P-glycoprotein modulation by valspodar and cyclosporin does not increase tumor uptake of doxorubicin administered via isolated lung perfusion to rats bearing sarcoma lung metastases.
    Anticancer Res. 2011;31:2121-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. HOLZER TR , Fulford AD, Arkins AM, Grondin JM, et al
    Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks.
    Anticancer Res. 2011;31:2073-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. MUSA MA , Badisa VL, Latinwo LM, Cooperwood J, et al
    Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines.
    Anticancer Res. 2011;31:2017-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
44. DIMITRAKOPOULOS FI , Papadaki H, Antonacopoulou AG, Kottorou A, et al
    Association of FOXP3 Expression with Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:1677-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. VINCENT EE , Elder DJ, Phillips L, Heesom KJ, et al
    Overexpression of the TXNDC5 Protein in Non-small Cell Lung Carcinoma.
    Anticancer Res. 2011;31:1577-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. OCVIRK J , Rebersek M, Boc M
    Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI.
    Anticancer Res. 2011;31:1777-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. DELPEUCH A , Leveque D, Rob L, Bergerat JP, et al
    Off-label Use of Oxaliplatin in Patients with Metastatic Breast Cancer.
    Anticancer Res. 2011;31:1765-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SCHALLIER D , Decoster L, de Greve J
    Pemetrexed-induced hyperpigmentation of the skin.
    Anticancer Res. 2011;31:1753-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ANDERSEN S , Donnem T, Al-Saad S, Al-Shibli K, et al
    Correlation and coexpression of HIFs and NOTCH markers in NSCLC.
    Anticancer Res. 2011;31:1603-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
50. MARAZ A , Furak J, Palfoldi R, Eller J, et al
    Roles of BCL-2 and MDR1 Expression in the Efficacy of Paclitaxel-based Lung Cancer Chemoradiation.
    Anticancer Res. 2011;31:1431-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. MALKI A , Bergmeier S
    Differential apoptotic effects of novel quinuclidinone analogs 8a and 8b in normal and lung cancer cell lines.
    Anticancer Res. 2011;31:1345-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. RESTREPO-ANGULO I , Sanchez-Torres C, Camacho J
    Human EAG1 Potassium Channels in the Epithelial-to-Mesenchymal Transition in Lung Cancer Cells.
    Anticancer Res. 2011;31:1265-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. HEDMAN M , Bergqvist M, Brattstrom D, Brodin O, et al
    Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.
    Anticancer Res. 2011;31:1125-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. YANAGAWA N , Tamura G, Oizumi H, Endoh M, et al
    Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status.
    Anticancer Res. 2011;31:1211-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. JASINSKI P , Zwolak P, Terai K, Vogel RI, et al
    MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling.
    Anticancer Res. 2011;31:1181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. YU Y , Luk F, Yang JL, Walsh WR, et al
    Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model.
    Anticancer Res. 2011;31:1147-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. CHUNDONG G , Uramoto H, Onitsuka T, Shimokawa H, et al
    Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis.
    Anticancer Res. 2011;31:1141-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
58. HIRAI Y , Yoshimasu T, Oura S, Ota F, et al
    Is Class III {beta}-Tubulin a True Predictive Marker of Sensitivity to Vinorelbine in Non-small Cell Lung Cancer? Chemosensitivity Data Evidence.
    Anticancer Res. 2011;31:999-1005.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. KANINTRONKUL Y , Worayuthakarn R, Thasana N, Winayanuwattikun P, et al
    Overcoming Multidrug Resistance in Human Lung Cancer with Novel Benzo[a]quinolizin-4-ones.
    Anticancer Res. 2011;31:921-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ONITSUKA T , Uramoto H, Tanaka F
    Lack of Direct Association between EGFR Mutations and ER Beta Expression in Lung Cancer.
    Anticancer Res. 2011;31:855-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. HERRERA VA , Zeindl-Eberhart E, Jung A, Huber RM, et al
    The Dual PI3K/mTOR Inhibitor BEZ235 Is Effective in Lung Cancer Cell Lines.
    Anticancer Res. 2011;31:849-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. NOJIRI K , Tanaka K, Nagano Y, Ueda M, et al
    Efficacy of Surgery for Lung Metastases from Colorectal Cancer Synchronous to or Following that for Liver Metastases.
    Anticancer Res. 2011;31:1049-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
63. SYRIGOS KN , Saif MW, Karapanagiotou EM, Oikonomopoulos G, et al
    The Need for Third-line Treatment in Non-small Cell Lung Cancer: An Overview of New Options.
    Anticancer Res. 2011;31:649-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. URAMOTO H , Hanagiri T
    The development of bronchopleural fistula in lung cancer patients after major surgery: 31 years of experience with 19 cases.
    Anticancer Res. 2011;31:619-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. LI D , Sakashita S, Morishita Y, Kano J, et al
    Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line.
    Anticancer Res. 2011;31:529-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. DESITTER I , Guerrouahen BS, Benali-Furet N, Wechsler J, et al
    A new device for rapid isolation by size and characterization of rare circulating tumor cells.
    Anticancer Res. 2011;31:427-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. PHILLIPS PG , Yalcin M, Cui H, Abdel-Nabi H, et al
    Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin.
    Anticancer Res. 2011;31:411-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
68. JAHNKE K , Keilholz U, Luftner D, Thiel E, et al
    Randomized Phase II Study of Paclitaxel and Carboplatin or Vinorelbine in Advanced Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:317-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. CSTOTH I , Anthoine G, Berghmans T, Mascaux C, et al
    C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib.
    Anticancer Res. 2011;31:281-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. HALIM H , Chunhacha P, Suwanborirux K, Chanvorachote P, et al
    Anticancer and Antimetastatic Activities of Renieramycin M, a Marine Tetrahydroisoquinoline Alkaloid, in Human Non-small Cell Lung Cancer Cells.
    Anticancer Res. 2011;31:193-201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. YANAGAWA N , Tamura G, Oizumi H, Endoh M, et al
    MAGE Expressions Mediated by Demethylation of MAGE Promoters Induce Progression of Non-small Cell Lung Cancer.
    Anticancer Res. 2011;31:171-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. VETVICKA V , Vetvickova J
    Procathepsin d and cytokines influence the proliferation of lung cancer cells.
    Anticancer Res. 2011;31:47-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. FREYER G , Duret A, Milano G, Chatelut E, et al
    Pharmacogenetic Tailoring of Irinotecan-based First-line Chemotherapy in Metastatic Colorectal Cancer: Results of a Pilot Study.
    Anticancer Res. 2011;31:359-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. URAMOTO H , Hanagiri T
    Two Cases with a Long-term Survival Following Multidisciplinary Treatment for Recurrent Breast Cancer After Surgery.
    Anticancer Res. 2011;31:277-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. HUANG SM , Lu KT, Wang YC
    ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G arrest in cancer cells and xenograft models.
    Anticancer Res. 2011;31:203-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. WASA J , Sugiura H, Kozawa E, Kohyama K, et al
    The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.
    Anticancer Res. 2011;31:123-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. MATSUMOTO G , Omi Y, Lee U, Kubota E, et al
    NK4 gene therapy combined with cisplatin inhibits tumour growth and metastasis of squamous cell carcinoma.
    Anticancer Res. 2011;31:105-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
78. TASSI R , Muto A, Rangan S, Vannini A, et al
    Response and Safety of Sunitinib in a Heavily Pre-treated Metastatic Non-Small Cell Lung Carcinoma Patient.
    Anticancer Res. 2010;30:5169-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. KARAHALIL B , Bohr VA, DE Souza-Pinto NC
    Base excision repair activities differ in human lung cancer cells and corresponding normal controls.
    Anticancer Res. 2010;30:4963-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. FUKAZAWA T , Maeda Y, Matsuoka J, Ono T, et al
    Targeting KRAS Mutation-bearing Lung Cancer In Vivo by Pulmonary Surfactant-Adenovirus-mediated Gene Transfer.
    Anticancer Res. 2010;30:4925-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. IMAI H , Kaira K, Oriuchi N, Shimizu K, et al
    Inhibition of L-type Amino Acid Transporter 1 Has Antitumor Activity in Non-small Cell Lung Cancer.
    Anticancer Res. 2010;30:4819-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. NAKAMURA H , Mochizuki A, Shinmyo T, Ando K, et al
    Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.
    Anticancer Res. 2010;30:5233-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. SCHALLIER D , Decoster L, Fontaine C, De Greve J, et al
    Pemetrexed-induced eyelid edema: incidence and clinical manifestations.
    Anticancer Res. 2010;30:5185-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. BONANNO L , Schiavon M, Nardo G, Bertorelle R, et al
    Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.
    Anticancer Res. 2010;30:5121-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. KOZAWA E , Sugiura H, Wasa J, Kohyama K, et al
    Suppression of tumour metastasis in a murine osteosarcoma model with anti-CD25 monoclonal antibody treatment.
    Anticancer Res. 2010;30:5019-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
86. BRUNO P , Pisani L, Ricci A, Falasca C, et al
    Cytology on Transbronchial Needle Aspiration (TBNA): Not Only for Lung Cancer.
    Anticancer Res. 2010;30:4769-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. URAMOTO H , Nakanishi R, Nagashima A, Uchiyama A, et al
    A Randomized Phase II Trial of Adjuvant Chemotherapy with Bi-weekly Carboplatin plus Paclitaxel versus Carboplatin plus Gemcitabine in Patients with Completely Resected Non-small Cell Lung Cancer.
    Anticancer Res. 2010;30:4695-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. JO UH , Whang YM, Sung JS, Kim YH, et al
    Methylation of AKAP12{alpha} Promoter in Lung Cancer.
    Anticancer Res. 2010;30:4595-600.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. URAMOTO H , Yamada S, Hanagiri T
    Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung.
    Anticancer Res. 2010;30:4717-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. MUSA MA , Badisa VL, Latinwo LM, Waryoba C, et al
    In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines.
    Anticancer Res. 2010;30:4613-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. DONG M , Rice L, Lepler S, Pampo C, et al
    Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.
    Anticancer Res. 2010;30:4405-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
92. SHUKUYA T , Ishiwata T, Hara M, Muraki K, et al
    Carboplatin plus Weekly Paclitaxel Treatment in Non-small Cell Lung Cancer Patients with Interstitial Lung Disease.
    Anticancer Res. 2010;30:4357-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. KOTSAKIS A , Hatzidaki D, Vamvakas L, Vardakis N, et al
    A Retrospective Analysis of Non-platinum-based First- and Second-line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer.
    Anticancer Res. 2010;30:4335-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. FUKAZAWA T , Maeda Y, Matsuoka J, Yamatsuji T, et al
    Inhibition of Myc Effectively Targets KRAS Mutation-positive Lung Cancer Expressing High Levels of Myc.
    Anticancer Res. 2010;30:4193-200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. LIU CJ , Hsia TC, Tsai RY, Sun SS, et al
    The Joint Effect of hOGG1 Single Nucleotide Polymorphism and Smoking Habit on Lung Cancer in Taiwan.
    Anticancer Res. 2010;30:4141-4145.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. URAMOTO H , Akyurek LM, Hanagiri T
    A positive relationship between filamin and VEGF in patients with lung cancer.
    Anticancer Res. 2010;30:3939-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. LORIOT Y , Mordant P, Brown BD, Bourhis J, et al
    Inhibition of BCL-2 in Small Cell Lung Cancer Cell Lines with Oblimersen, an Antisense BCL-2 Oligodeoxynucleotide (ODN): In Vitro and In Vivo Enhancement of Radiation Response.
    Anticancer Res. 2010;30:3869-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. URAMOTO H , Onitsuka T, Shimokawa H, Hanagiri T, et al
    TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.
    Anticancer Res. 2010;30:4309-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. PELOSI G , Fumagalli C, Trubia M, Sonzogni A, et al
    Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.
    Anticancer Res. 2010;30:4269-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. MAAS KW , El Sharouni SY, Phernambucq EC, Stigt JA, et al
     Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.
     Anticancer Res. 2010;30:4237-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. MATSUMOTO I , Ohta Y, Waseda R, Tamura M, et al
     Vitamin B2 as a tracer for intraoperative pulmonary sentinel node navigation surgery.
     Anticancer Res. 2010;30:4109-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
102. TAKAHASHI H , Kurishima K, Ishikawa H, Kagohashi K, et al
     Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis.
     Anticancer Res. 2010;30:3833-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. SION-VARDY N , Freedman J, Lazarov I, Bolotin A, et al
     p27kip1 Expression in non-small cell lung cancer is not an independent prognostic factor.
     Anticancer Res. 2010;30:3699-704.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. KIM HK , Jung HY, Lim S, Sung JS, et al
     A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population.
     Anticancer Res. 2010;30:3621-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. WANG J , Wang H, Zhao L, Fan S, et al
     Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines.
     Anticancer Res. 2010;30:3593-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. GUNTUR VP , Waldrep JC, Guo JJ, Selting K, et al
     Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro.
     Anticancer Res. 2010;30:3557-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. ZHENG M , Yang J, Xu X, Sebolt JT, et al
     Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
     Anticancer Res. 2010;30:3321-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. MONTEIL J , Vergnenegre A, Bertin F, Dalmay F, et al
     Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging.
     Anticancer Res. 2010;30:3811-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. JEONG WC , Kim KJ, Ju HW, Back HK, et al
     Cytoplasmic phospholipase A2 metabolites play a critical role in pulmonary tumor metastasis in mice.
     Anticancer Res. 2010;30:3421-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. ONO K , Uramoto H, Hanagiri T
     Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.
     Anticancer Res. 2010;30:3273-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
111. SAWACHI K , Shimada Y, Taniguchi H, Hirota K, et al
     Cytotoxic effects of activated alveolar macrophages on lung carcinoma cells via cell-to-cell contact and nitric oxide.
     Anticancer Res. 2010;30:3135-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. KATO M , Goto S, Soma G
     Lymphokine-activated killer cell therapy combined with high-dose glucocorticoid showed clinical efficacy towards advanced lung carcinoma.
     Anticancer Res. 2010;30:3125-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. TANIGUCHI H , Shimada Y, Sawachi K, Hirota K, et al
     Lipopolysaccharide-activated alveolar macrophages having cytotoxicity toward lung tumor cells through cell-to-cell binding-dependent mechanism.
     Anticancer Res. 2010;30:3159-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. HIROTA K , Oishi Y, Taniguchi H, Sawachi K, et al
     Antitumor effect of inhalatory lipopolysaccharide and synergetic effect in combination with cyclophosphamide.
     Anticancer Res. 2010;30:3129-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
115. TOMITA M , Shimizu T, Ayabe T, Yonei A, et al
     Prognostic Significance of Tumour Marker Index Based on Preoperative CEA and CYFRA 21-1 in Non-small Cell Lung Cancer.
     Anticancer Res. 2010;30:3099-102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. MINNITI G , Salvati M, Muni R, Lanzetta G, et al
     Stereotactic Radiosurgery plus Whole-brain Radiotherapy for Treatment of Multiple Metastases from Non-small Cell Lung Cancer.
     Anticancer Res. 2010;30:3055-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. SUGAYA M , Uramoto H, Uchiyama A, Nagashima A, et al
     Phase II Trial of Adjuvant Chemotherapy with Bi-Weekly Carboplatin Plus Paclitaxel in Patients with Completely Resected Non-small Cell Lung Cancer.
     Anticancer Res. 2010;30:3039-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. BAKA S , Agelaki S, Kotsakis A, Veslemes M, et al
     Phase III Study Comparing Sequential Versus Alternate Administration of Cisplatin-Etoposide and Topotecan as First-line Treatment in Small Cell Lung Cancer.
     Anticancer Res. 2010;30:3031-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. YAMAMOTO N , Yamanaka T, Ichinose Y, Kubota K, et al
     Pooled analysis of s-1 trials in non-small cell lung cancer according to histological type.
     Anticancer Res. 2010;30:2985-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. YASUDA M , Hanagiri T, Shigematsu Y, Onitsuka T, et al
     Identification of a tumour associated antigen in lung cancer patients with asbestos exposure.
     Anticancer Res. 2010;30:2631-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. RICE SD , Heinzman JM, Brower SL, Ervin PR, et al
     Analysis of chemotherapeutic response heterogeneity and drug clustering based on mechanism of action using an in vitro assay.
     Anticancer Res. 2010;30:2805-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. KIM EJ , Kim H, Lee S, Kang JW, et al
     Melphalan modulates the expression of E7-specific biomarkers in E7-Tg mice.
     Anticancer Res. 2010;30:2773-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. URAMOTO H , Iwata T, Onitsuka T, Shimokawa H, et al
     Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma.
     Anticancer Res. 2010;30:2513-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. ADAMS VR , Deremer DL, Stevich B, Mattingly CA, et al
     Anticancer activity of novel unnatural synthetic isoprenoids.
     Anticancer Res. 2010;30:2505-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. HARDY TM , Kumar MS, Smith ML
     RB stabilizes XPC and promotes cellular NER.
     Anticancer Res. 2010;30:2483-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
126. WU SH , Hang LW, Yang JS, Chen HY, et al
     Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.
     Anticancer Res. 2010;30:2125-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. JINN Y , Inase N
     Connexin 43, E-cadherin, beta-catenin and ZO-1 expression, and aberrant methylation of the connexin 43 gene in NSCLC.
     Anticancer Res. 2010;30:2271-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. HU A , Wu X, Li Z, Wang H, et al
     A novel gene delivery system targeting Tie2 for cancer gene therapy.
     Anticancer Res. 2010;30:1999-2004.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: